IL1B and type 2 diabetes mellitus: In patients with T2DM, serum levels of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and CRP (C-reactive protein) are elevated and have been widely used as a biomarker of T2DM1, 2, 3, 4.